Get the latest research to your inbox
- PhD studentInstitute for Molecular Bioscience
- Senior Advancement OfficerInstitute for Molecular Bioscience
- Postdoctoral Research FellowInstitute for Molecular Bioscience
- Professor of BiochemistryDept of Chemistry, Umeå University (Sweden)
Cater Lab Team
Group Leader
Dr Rosemary Cater
Senior Research Fellow & Group LeaderInstitute for Molecular BioscienceResearcher profile is public:1Supervisor:Researcher biography:Rosemary Cater was recently recruited to UQ's Institute for Molecular Bioscience as a Group Leader and ARC DECRA Fellow. She utilizes structural biology, membrane protein biochemistry, and biophysics to understand some of the brain's most elusive yet important proteins. The overarching goal of the Cater Lab is to understand molecular mechanisms of transport at the blood-brain barrier.
Dr. Cater was awarded her PhD in 2017 from the University of Sydney, and from 2017-2023 she was a Post-Doctoral Fellow in the laboratory of Prof. Filippo Mancia at Columbia University, New York, USA. Here she used single-particle cryo-electron microscopy and antigen-binding technology to determine structures of small membrane proteins.
Highlights of her career thus far include:
- She has been awarded an ARC DECRA, an NIH K99/R00 career transition award.
- She received a 2022 Blavatnik Regional Finalist Award in Chemistry – a highly competitive award for outstanding post-doctoral research presented at the New York Academy of Sciences Annual Gala.
- She was selected as one was 1 of 120 young leaders invited from 46 countries to the 2022 Science and Technology in Society Forum (Kyoto) to discuss humanity's global challenges with politicians, CEOs, and Nobel Laureates.
- She was appointed as one of twelve Simons Society Fellows (2018-2022) – one of the USA's most competitive post-doctoral fellowships, founded in New York by billionaire philanthropist Jim Simons.
- She received a Robin Anders Young Investigator Award at the Lorne Protein Structure and Function 2020 Meeting – one of Australia's most competitive awards for early-career protein scientists.
Researchers
- PhD StudentInstitute for Molecular Bioscience
- Higher degree by research (PhD) studentInstitute for Molecular Bioscience
Smythe Group
Group Leader
Associate Professor Mark Smythe
Researcher profile is public:1Supervisor:Body:Highlights
Associate Professor Mark Smythe is a medicinal chemist. His expertise lies in transforming interesting molecules into high-value medicines.
His methodology for translating academic discoveries into commercially viable companies has achieved great success. He founded biotech company Protagonist Therapeutics in 2001, which is now a publicly listed company with several compounds in human clinical trials and several others sold to pharmaceutical partners. He and his team worked for 15 years to develop an approach to replace injectable drugs with pills. They took high potency, highly selective peptides that are traditionally broken down quickly by the body, and made them stronger. So, diseases that used to require ‘big-molecule’ injections we can now treat with a ‘constrained peptide’ pill. This has several advantages to the patients and addresses unmet medical needs of various diseases
Associate Professor Smythe has always had a focus on applied research, making things. He studied a Bachelor of Science with Honours in Townsville. He wanted a PhD that was applied, so he took at position at Biota with a focus on Influenza. After working in the US, he accepted a position at the then 3D Centre in Queensland, now the Institute for Molecular Bioscience (IMB). At IMB he uses his expertise to translate discoveries into new drug candidates.
Connect
Researchers
Students
Dr Chynna-Loren Sheremeta
PhD student & Research OfficerInstitute for Molecular BioscienceResearcher profile is public:0Supervisor:
Pages
Strawberry DNA extraction activity
Extract and view DNA from a strawberry using common household ingredients.
Get started
The Edge: Genetics
People have known for thousands of years that parents pass traits to their children, but it is only relatively recently that our technology has caught up to our curiosity, enabling us to delve into the mystery of how this inheritance occurs, and the implications for predicting, preventing and treating disease.
Subscribe to our newsletter
Get the latest research straight to your inbox.
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.
General enquiries
+61 7 3346 2222
imb@imb.uq.edu.au
Media enquiries
IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.
Support us
Donate to research
100% of donations go to the cause